This study tests whether a combination of anti-inflammatory and heart-protecting drugs can reduce symptoms and prevent heart damage in people with Long COVID who have ongoing heart inflammation. About 279 adults with persistent heart-related symptoms and MRI evidence of inflammat…
Phase: PHASE3 • Sponsor: Valentina Puentmann • Aim: Disease control
Last updated May 11, 2026 20:50 UTC